Nuveen, LLC Fennec Pharmaceuticals Inc. Transaction History

Nuveen, LLC

  • $363 Billion
  • Q3 2025

A detailed history of Nuveen, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Nuveen, LLC holds 26,006 shares of FENC stock, worth $210,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,006
Previous 26,006 -0.0%
Holding current value
$210,648
Previous $215,000 11.16%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$5.54 - $7.02 $144,073 - $182,562
26,006 New
26,006 $158,000

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $211M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email